The letter by Papapetropoulos and colleagues presents an additional study correlating ␣-synuclein expression levels and sporadic PD. Previously we and others published studies of mRNA levels of SNCA in PD brains that have been performed using different methods. Some are in agreement with our results
Polymorphisms of the α-synuclein promoter: expression analyses and association studies in Parkinson's disease
✍ Scribed by C. Holzmann; R. Krüger; A. M. M. Vieira Saecker; I. Schmitt; L. Schöls; K. Berger; O. Riess
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 201 KB
- Volume
- 110
- Category
- Article
- ISSN
- 1435-1463
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Genetic variation in __fibroblast growth factor 20__ (__FGF20__) has been associated with risk of Parkinson's disease (PD). Functional evidence suggested the T allele of one SNP, rs12720208 C/T, altered PD risk by increasing FGF20 and α‐synuclein protein levels. Herein we report our ass
## Abstract Inflammatory events may contribute to the pathogenesis of Parkinson's disease (PD). We conducted a case‐control study in a cohort of 369 PD cases and another cohort of 326 ethnically matched controls to investigate the association of tumor necrosis factor‐α (__TNF‐α__) promoter single n
## Abstract The α‐synuclein Rep1 polymorphism was studied in patients and controls in an ethnic Greek population. There was an association of allele 2 with risk of Parkinson's disease (PD; adjusted odd ratio = 3.25; 95% CI = 1.80–5.87). Survival analyses (Cox proportional hazards models) were emplo